Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome (SPHINX)

This study has been completed.

Study NCT00721552 Information provided by VU University Medical Center

First Received on July 22, 2008. Last Updated on June 28, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Diabetes Mellitus
Steroid Diabetes
Glucocorticoid-induced Diabetes
Beta-cell Function

Additional conditions recognized in this trial

Metabolic Syndrome X

More general conditions related to this trial

Endocrine System Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases

Interventions listed in this trial

Sitagliptin 100 mg
Prednisolone 30 mg
Sitagliptin-placebo
Prednisolone-placebo

Additional drug interventions recognized in this trial

Glucocorticoids
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Sitagliptin

Sponsors listed in this trial

VU University Medical Center

Back to top of Main Content